Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine

GAITHERSBURG, Md., Feb. 14, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing...

Related Keywords

Mexico ,India ,Singapore ,Laura Keenan Lindsey ,Erika Schultz ,Stanleyc Erck ,Alexandra Roy ,Ali Chartan ,Linkedin ,World Health Organization ,European Commission ,Nasdaq ,Exchange Commission ,Singapore Health Sciences Authority ,Administration Of Nuvaxovid ,Serum Institute Of India ,Novavax Inc ,Chief Executive Officer ,New England Journal ,Product Characteristics ,Prescribing Information ,Important Safety Information ,Package Leaflet ,Serum Institute ,World Health ,Financial Condition ,Novavax Annual Report ,Quarterly Reports ,Keenan Lindsey ,